FAP and neoplasm: Another study showed anti-tumor efficacy and no side effects in an immunodeficient mouse model of lung cancer, while the final study, done in a mesothelioma model, showed survival benefits for tumor-bearing mice, but toxicities could not be evaluated, as the antibody did not react with mouse FAP [137,171,172,173].